Clinical Trials

    A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL) (TRANSCEND FL)

    Investigator: Sai ravi kiran Pingali

    Study Coordinator: Danielle Sewall

    Status: Enrolling

    ClinicalTrials.gov Number: NCT04245839

    Phone: 346.238.2674

    Protocol Number: PRO00038360

    Description


    This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/r FL or MZL.